2011
DOI: 10.1055/s-0031-1272222
|View full text |Cite
|
Sign up to set email alerts
|

Phase I Studie mit Pemetrexed, Carboplatin und Sorafenib als Erstlinientherapie bei Patienten mit metastasiertem NSCLC

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles